Keywords: orchid, gsk, snp, collaboration, bioscience, glaxosmithkline, signed
Orchid and GSK in SNP collaboration
Article | 15 November 2001
Orchid Bioscience and GlaxoSmithKline have signed a collaborationagreement on a genome-wide validation of single nucleotide polymorphisms for pharmacogenetic studies. As ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
